These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 9599604)

  • 1. [Free radical mechanisms of radiation modification of DNA sugar fragment].
    Sharpatyĭ VA
    Radiats Biol Radioecol; 1997; 37(4):508-11. PubMed ID: 9599604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interactions of inhibitor of free radical reactions and 2-deoxyribosyl macroradicals].
    Kuzurman PA; Sharpatyĭ VA
    Radiats Biol Radioecol; 1998; 38(2):147-55. PubMed ID: 9633616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. THE ROLE OF THE COMPONENTS OF COMPLEMENT IN SPECIFIC IMMUNE FIXATION.
    Pillemer L; Seifter S; Ecker EE
    J Exp Med; 1942 Apr; 75(4):421-35. PubMed ID: 19871194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement as a mediator of inflammation. 3. Purification of the activity with anaphylatoxin properties generated by interaction of the first four components of complement and its identification as a cleavage product of C'3.
    da Silva WD; Eisele JW; Lepow IH
    J Exp Med; 1967 Dec; 126(6):1027-48. PubMed ID: 6069927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. STUDIES ON IMMUNE HUMAN HEMOLYSIS : II. THE DONATH-LANDSTEINER REACTION AS A MODEL SYSTEM FOR STUDYING THE MECHANISM OF ACTION OF COMPLEMENT AND THE ROLE OF C'1 AND C'1 ESTERASE.
    Hinz CF; Picken ME; Lepow IH
    J Exp Med; 1961 Jan; 113(1):193-218. PubMed ID: 19867184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FUNCTION OF COMPONENTS OF COMPLEMENT IN IMMUNE HEMOLYSIS.
    Pillemer L; Seifter S; Chu F; Ecker EE
    J Exp Med; 1942 Jul; 76(1):93-101. PubMed ID: 19871223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Modification of complement factors and their inhibitors during meningococcal sepsis (author's transl)].
    Blanco A; Solís P; Alvarez Guisasola FJ; Valbuena C; Gómez C; Prieto P; Ruíz C
    An Esp Pediatr; 1980 Aug; 13(8):679-88. PubMed ID: 7436149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation and functional significance of a molecular complex derived from the second and the fourth component of human complement.
    Müller-Eberhard HJ; Polley MJ; Calcott MA
    J Exp Med; 1967 Feb; 125(2):359-80. PubMed ID: 6019133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Determination of the total complement activity of serum and of 4 fractions: C'1, C'2, C'3, C'4].
    Brécy H; André A; Hartmann L
    Rev Fr Etud Clin Biol; 1967 Dec; 12(10):1024-8. PubMed ID: 5598511
    [No Abstract]   [Full Text] [Related]  

  • 10. [Determination of the fractions of complement (C'1, C'2, C'3, C'4) in hypocomplimentary glomerulopathies].
    Lagrue G; Brécy H; Bariéty J; Milliez P; Hartmann L
    Rev Fr Etud Clin Biol; 1967 Dec; 12(10):990-5. PubMed ID: 5598513
    [No Abstract]   [Full Text] [Related]  

  • 11. [The radiation modification of the sugar fragment in DNA: the formation of breaks, a change in polymer conformation and the transfer of the damage to the base].
    Sharpatyĭ VA
    Radiobiologiia; 1992; 32(2):180-93. PubMed ID: 1598390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serum complement and C'1, C'2, C'3 and C'4 components in rheumatoid arthritis and collagen diseases].
    Pietruska Z
    Pol Tyg Lek; 1972 Dec; 27(51):2010-3. PubMed ID: 4653713
    [No Abstract]   [Full Text] [Related]  

  • 13. [Study of the mechanism of the fall in complement levels in the synovial fluid in rheumatoid arthritis. I. Variations in the levels of C'1, C'4, C'2 and C'3 and total complement].
    Peltier AP; Vial MC; de Sèze S
    Pathol Biol (Paris); 1970 Nov; 18(21):959-67. PubMed ID: 4921319
    [No Abstract]   [Full Text] [Related]  

  • 14. Complement dependent immune phagocytosis. I. Requirements for C'1, C'4, C'2, C'3.
    Gigli I; Nelson RA
    Exp Cell Res; 1968 Jul; 51(1):45-67. PubMed ID: 5661952
    [No Abstract]   [Full Text] [Related]  

  • 15. [Determination of total complementary activity and of its 4 fractions: C'1, C'2, C'3 and C'4 in the serum and urine].
    Hartmann L; Brécy H
    Ann Biol Clin (Paris); 1969; 27(7):559-70. PubMed ID: 5354248
    [No Abstract]   [Full Text] [Related]  

  • 16. [Irregular behavior of complement in coeliac disease (author's transl)].
    Blanco A; Alonso M; Solís P; Calvo C; Catoira A; Sánchez Villares E
    An Esp Pediatr; 1981 Nov; 15(5):449-54. PubMed ID: 7332146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of adenylic acid with alkaline earth metal ions in the crystalline solid and aqueous solution. Evidence for the sugar C'2-endo/anti, C'3-endo/anti and C'4-exon/anti conformational changes.
    Tajmir-Riahi HA
    Biochim Biophys Acta; 1990 Sep; 1087(1):49-54. PubMed ID: 2119235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement.
    Cochrane CG; Müller-Eberhard HJ
    J Exp Med; 1968 Feb; 127(2):371-86. PubMed ID: 4383923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The second component of human complement: its isolation, fragmentation by C'1 esterase, and incorporation into C'3 convertase.
    Polley MJ; Müller-Eberhard HJ
    J Exp Med; 1968 Sep; 128(3):533-51. PubMed ID: 5666963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on immune cellular injury. II. Functional role of C'1 esterase in immune cytotoxicity.
    LEPOW IH; ROSS A
    J Exp Med; 1960 Dec; 112(6):1107-20. PubMed ID: 13761024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.